1256 related articles for article (PubMed ID: 27226369)
41. Lentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected mice.
Pfeifer A; Eigenbrod S; Al-Khadra S; Hofmann A; Mitteregger G; Moser M; Bertsch U; Kretzschmar H
J Clin Invest; 2006 Dec; 116(12):3204-10. PubMed ID: 17143329
[TBL] [Abstract][Full Text] [Related]
42. PrP(Sc) of scrapie 263K propagates efficiently in spleen and muscle tissues with protein misfolding cyclic amplification.
Shi S; Dong CF; Wang GR; Wang X; An R; Chen JM; Shan B; Zhang BY; Xu K; Shi Q; Tian C; Gao C; Han J; Dong XP
Virus Res; 2009 Apr; 141(1):26-33. PubMed ID: 19162101
[TBL] [Abstract][Full Text] [Related]
43. Prion diseases and emerging prion diseases.
Yokoyama T; Mohri S
Curr Med Chem; 2008; 15(9):912-6. PubMed ID: 18473798
[TBL] [Abstract][Full Text] [Related]
44. Generation of genuine prion infectivity by serial PMCA.
Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
[TBL] [Abstract][Full Text] [Related]
45. Prion replication without host adaptation during interspecies transmissions.
Bian J; Khaychuk V; Angers RC; Fernández-Borges N; Vidal E; Meyerett-Reid C; Kim S; Calvi CL; Bartz JC; Hoover EA; Agrimi U; Richt JA; Castilla J; Telling GC
Proc Natl Acad Sci U S A; 2017 Jan; 114(5):1141-1146. PubMed ID: 28096357
[TBL] [Abstract][Full Text] [Related]
46. Preventing misfolding of the prion protein by trimethylamine N-oxide.
Bennion BJ; DeMarco ML; Daggett V
Biochemistry; 2004 Oct; 43(41):12955-63. PubMed ID: 15476389
[TBL] [Abstract][Full Text] [Related]
47. Ex vivo propagation of infectious sheep scrapie agent in heterologous epithelial cells expressing ovine prion protein.
Vilette D; Andreoletti O; Archer F; Madelaine MF; Vilotte JL; Lehmann S; Laude H
Proc Natl Acad Sci U S A; 2001 Mar; 98(7):4055-9. PubMed ID: 11259656
[TBL] [Abstract][Full Text] [Related]
48. Synthetic prions and other human neurodegenerative proteinopathies.
Le NT; Narkiewicz J; Aulić S; Salzano G; Tran HT; Scaini D; Moda F; Giachin G; Legname G
Virus Res; 2015 Sep; 207():25-37. PubMed ID: 25449570
[TBL] [Abstract][Full Text] [Related]
49. Transgenic Rabbits Expressing Ovine PrP Are Susceptible to Scrapie.
Sarradin P; Viglietta C; Limouzin C; Andréoletti O; Daniel-Carlier N; Barc C; Leroux-Coyau M; Berthon P; Chapuis J; Rossignol C; Gatti JL; Belghazi M; Labas V; Vilotte JL; Béringue V; Lantier F; Laude H; Houdebine LM
PLoS Pathog; 2015 Aug; 11(8):e1005077. PubMed ID: 26248157
[TBL] [Abstract][Full Text] [Related]
50. Bioassay of prion-infected blood plasma in PrP transgenic Drosophila.
Thackray AM; Andreoletti O; Bujdoso R
Biochem J; 2016 Dec; 473(23):4399-4412. PubMed ID: 27733649
[TBL] [Abstract][Full Text] [Related]
51. The role of PrP in health and disease.
Flechsig E; Weissmann C
Curr Mol Med; 2004 Jun; 4(4):337-53. PubMed ID: 15354865
[TBL] [Abstract][Full Text] [Related]
52. Recombinant prion protein refolded with lipid and RNA has the biochemical hallmarks of a prion but lacks in vivo infectivity.
Timmes AG; Moore RA; Fischer ER; Priola SA
PLoS One; 2013; 8(7):e71081. PubMed ID: 23936256
[TBL] [Abstract][Full Text] [Related]
53. Assessment of the PrPc Amino-Terminal Domain in Prion Species Barriers.
Davenport KA; Henderson DM; Mathiason CK; Hoover EA
J Virol; 2016 Dec; 90(23):10752-10761. PubMed ID: 27654299
[TBL] [Abstract][Full Text] [Related]
54. Peptides and proteins in neurodegenerative disease: helix propensity of a polypeptide containing helix 1 of the mouse prion protein studied by NMR and CD spectroscopy.
Liu A; Riek R; Zahn R; Hornemann S; Glockshuber R; Wüthrich K
Biopolymers; 1999; 51(2):145-52. PubMed ID: 10397798
[TBL] [Abstract][Full Text] [Related]
55. Copper induces increased beta-sheet content in the scrapie-susceptible ovine prion protein PrPVRQ compared with the resistant allelic variant PrPARR.
Wong E; Thackray AM; Bujdoso R
Biochem J; 2004 May; 380(Pt 1):273-82. PubMed ID: 14969585
[TBL] [Abstract][Full Text] [Related]
56. Deletion of beta-strand and alpha-helix secondary structure in normal prion protein inhibits formation of its protease-resistant isoform.
Vorberg I; Chan K; Priola SA
J Virol; 2001 Nov; 75(21):10024-32. PubMed ID: 11581371
[TBL] [Abstract][Full Text] [Related]
57. Synthetic scrapie infectivity: interaction between recombinant PrP and scrapie brain-derived RNA.
Simoneau S; Thomzig A; Ruchoux MM; Vignier N; Daus ML; Poleggi A; Lebon P; Freire S; Durand V; Graziano S; Galeno R; Cardone F; Comoy E; Pocchiari M; Beekes M; Deslys JP; Fournier JG
Virulence; 2015; 6(2):132-44. PubMed ID: 25585171
[TBL] [Abstract][Full Text] [Related]
58. Conformational variation between allelic variants of cell-surface ovine prion protein.
Thackray AM; Yang S; Wong E; Fitzmaurice TJ; Morgan-Warren RJ; Bujdoso R
Biochem J; 2004 Jul; 381(Pt 1):221-9. PubMed ID: 15070397
[TBL] [Abstract][Full Text] [Related]
59. Interaction of Peptide Aptamers with Prion Protein Central Domain Promotes α-Cleavage of PrP
Corda E; Du X; Shim SY; Klein AN; Siltberg-Liberles J; Gilch S
Mol Neurobiol; 2018 Oct; 55(10):7758-7774. PubMed ID: 29460268
[TBL] [Abstract][Full Text] [Related]
60. Molecular biology and genetics of prion diseases.
Prusiner SB
Philos Trans R Soc Lond B Biol Sci; 1994 Mar; 343(1306):447-63. PubMed ID: 7913765
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
